Interesting facts
Interesting Facts About 5-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,3-diol
This fascinating compound, commonly referred to as a derivative of isopropylaminoethyl benzene diol, demonstrates a unique structure that is significant in the field of medicinal chemistry. Here are some captivating points about this compound:
- Pharmacological Significance: Compounds similar to this one often exhibit biological activity, being explored for their roles in treating various health conditions, particularly in neuropharmacology.
- Structure-Activity Relationship (SAR): Understanding how the different functional groups within this molecule affect its activity can provide insights into drug design and development.
- Potential Applications: Research indicates that such compounds may have implications in the treatment of psychiatric disorders, with the isopropylamino moiety potentially enhancing binding affinity to specific receptors.
- Chiral Centers: The presence of chiral centers in the structure indicates that enantiomers could exhibit different biological activities, which is a vital consideration in drug formulation.
- Synthetic Pathways: The synthesis of this compound involves multi-step organic reactions, showcasing the intricate process of creating pharmaceuticals in the lab.
As a scientist, exploring the nuances of compounds such as 5-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,3-diol not only expands our understanding of chemical properties but also opens doors to innovative therapeutic solutions.
In the words of renowned chemist Linus Pauling, "The best way to have a good idea is to have a lot of ideas." Exploring such compounds allows us to foster a myriad of ideas in the ever-expanding field of medicinal chemistry.
Synonyms
metaproterenol
ORCIPRENALINE
586-06-1
Alupent
Orciprenalina
Orciprenalinum
Orciprenalinum [INN-Latin]
Orciprenalina [INN-Spanish]
Orciprenaline [INN]
Prometa
Orciprenaline (INN)
CCRIS 9017
5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol
Orciprenaline [INN:BAN]
EINECS 209-569-1
(RS)-1-(3,5-Dihydroxyphenyl)-2-isopropylaminoethanol
BRN 2807247
CHEBI:6792
53QOG569E0
3,5-Dihydroxy-alpha-((isopropylamino)methyl)benzyl alcohol
5-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}benzene-1,3-diol
CHEMBL776
METAPROTERENOL [MI]
NSC-757089
1,3-Benzenediol, 5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-
METAPROTERENOL [VANDF]
ORCIPRENALINE [WHO-DD]
DTXSID8048529
NSC 757089
Benzyl alcohol, 3,5-dihydroxy-alpha-((isopropylamino)methyl)-
1,3-Benzenediol, 5-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]-
Orciprenalinum (INN-Latin)
Orciprenalina (INN-Spanish)
SR-01000075168
rac-5-(1-hydroxy-2-(isopropylamino)ethyl)benzene-1,3-diol
rac-5-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,3-diol
Orciprenalin
5-(1-hydroxy-2-((propan-2-yl)amino)ethyl)benzene-1,3-diol
rac-5-(1-hydroxy-2-(propan-2-ylamino)ethyl)benzene-1,3-diol
rac-5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol
UNII-53QOG569E0
rac-orciprenaline
(RS)-orciprenaline
racemic orciprenaline
(+-)-orciprenaline
Spectrum_000925
Prestwick0_000505
Prestwick1_000505
Prestwick2_000505
Prestwick3_000505
Spectrum2_000096
Spectrum3_000492
Spectrum4_000044
Spectrum5_000952
SCHEMBL4270
Lopac0_000734
BSPBio_000429
BSPBio_001983
KBioGR_000507
KBioSS_001405
DivK1c_000645
SPECTRUM1500390
SPBio_000052
SPBio_002350
BPBio1_000473
GTPL7250
DTXCID9027996
CHEBI:82719
CHEBI:83329
HMS502A07
HY-B1276A
KBio1_000645
KBio2_001405
KBio2_003973
KBio2_006541
KBio3_001483
R03AB03
R03CB03
NINDS_000645
HMS1920L09
HMS2091D04
HMS3259J13
Pharmakon1600-01500390
1,3-Benzenediol, 5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-(9CI)
BDBM50295572
CCG-38914
NSC757089
AKOS022506181
DB00816
NC00651
SDCCGSBI-0050712.P005
IDI1_000645
NCGC00015655-02
NCGC00015655-03
NCGC00015655-04
NCGC00015655-05
NCGC00015655-06
NCGC00015655-14
NCGC00094718-01
NCGC00094718-02
NCGC00094718-03
SBI-0050712.P004
AB00052037
CS-0013668
NS00002953
C07144
D08300
EN300-142650
1-(3,5-Dihydroxyphenyl)-2-isopropylaminoethanol
AB00052037_09
AB00052037_10
L000678
Q416473
SR-01000075168-1
SR-01000075168-4
BRD-A07780951-001-06-3
BRD-A07780951-001-08-9
BRD-A07780951-065-09-2
BRD-A07780951-065-10-0
5-(1-Hydroxy-2-(isopropylamino)ethyl)benzene-1,3-diol
5-(1-Hydroxy-2-isopropylamino-ethyl)-benzene-1,3-diol
5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol
5-[1-Hydroxy-2-(isopropylamino)ethyl]-1,3-benzenediol #
[2-(3,5-Dihydroxy-phenyl)-2-hydroxy-ethyl]-isopropyl-ammonium
1,3-Benzenediol, 5-1-hydroxy-2-(1-methylethyl)aminoethyl-
3,5-Dihydroxy-.alpha.-((isopropylamino)methyl)benzyl alcohol
benzene, 1,3-dihydroxy-5-(1-hydroxy-2-isopropylamino)ethyl-
5-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}benzene-1,3-diol, 6
Benzyl alcohol, 3,5-dihydroxy-.alpha.-((isopropylamino)methyl)-
[2-(3,5-Dihydroxy-phenyl)-2-hydroxy-ethyl]-isopropyl-ammonium (orciprenaline)
209-569-1
Solubility of 5-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,3-diol
The solubility characteristics of the compound 5-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,3-diol (C8H11NO3) play a pivotal role in its application and behavior in various environments. Here are some insights into its solubility:
In conclusion, while solubility can be influenced by multiple factors, it's important to remember that it is best evaluated under specific conditions. As they say, "The right conditions make all the difference!"